What question did this study set out to answer?

Synthesize current clinical evidence regarding diagnostic challenges, overdiagnosis, optimal anticoagulation strategies, and surveillance outcomes for patients presenting with isolated subsegmental pulmonary embolism.

September 10, 2026CureusOpen Access

Imaging Pulmonary Embolism in the Era of Subsegmental Clots: What the Internist Needs to Know About Overdiagnosis, Anticoagulation, and Follow-Up

Q: What is the clinical evidence from this study?

Study design: Review. Population: Subsegmental pulmonary embolism. Intervention: Anticoagulation vs. Observation.

View Full Paper

Ask AI

Bookmark

Key result

Anticoagulation for isolated subsegmental PE lacks randomized trials despite low ~0.9% observational recurrent VTE rates.

Why the study?

Increased detection of subsegmental pulmonary embolism has raised critical questions regarding overdiagnosis, diagnostic variability, and optimal anticoagulation strategies in low-risk patients.

Does anticoagulation improve outcomes compared to observation in patients with isolated subsegmental pulmonary embolism?

Design

Review

Authors

SVSri Vaibhav R V.JMJai C Machur SGSai Tejaswini Goruganthu

Discussion

Member takes

Implication

Supports observation without anticoagulation in selected low-risk patients; leaves open optimal management pending randomized trials.

Key Points

Synthesize current clinical evidence regarding diagnostic challenges, overdiagnosis, optimal anticoagulation strategies, and surveillance outcomes for patients presenting with isolated subsegmental pulmonary embolism.
Searched PubMed, Scopus, and Google Scholar databases from January 2014 to March 2026 using targeted terms for subsegmental pulmonary embolism, anticoagulation, and overdiagnosis.
Identified and evaluated observational cohorts, systematic reviews, meta-analyses, randomized trial protocols, and society clinical practice guidelines addressing subsegmental pulmonary embolism.
Isolated subsegmental pulmonary embolism accounts for approximately 10% of diagnosed pulmonary embolism cases, with increased detection attributed to advanced multidetector computed tomography pulmonary angiography.
Anticoagulation therapy carries major bleeding risks of up to 5% in certain populations, while short-term recurrence rates for subsegmental clots do not differ significantly from proximal pulmonary embolism.
In a screened coronary computed tomography angiography cohort, 45.5% of pulmonary emboli missed on initial radiology interpretation involved segmental or subsegmental arterial branches.

Structured PICO

Does anticoagulation improve outcomes compared to observation in patients with isolated subsegmental pulmonary embolism?

Population

A narrative review synthesizing current evidence on the epidemiology, diagnostic challenges, treatment controversies, and outcomes of subsegmental pulmonary embolism.

Intervention

Anticoagulation

Comparator

Observation without anticoagulation, or proximal pulmonary embolism

Outcome

Recurrent venous thromboembolism (VTE) and major bleedinghard clinical

This review highlights clinical equipoise regarding the net benefit of anticoagulation for low-risk isolated SSPE due to low recurrence rates and non-trivial bleeding risks, emphasizing the need for randomized trials.

Limitations

Lack of randomized controlled trial data to guide anticoagulation decisions
Substantial inter-observer variability in SSPE diagnosis
Observational data are limited by selection bias
Absence of untreated recurrence rate data prevents formal net clinical benefit modeling
Observational designs and selection bias in available data

Cite This Study

V. et al. (2026) conducted a review in Subsegmental pulmonary embolism. Anticoagulation vs. Observation was evaluated. Anticoagulation for isolated subsegmental pulmonary embolism lacks randomized trial evidence, while observational data show low 90-day recurrent venous thromboembolism rates of approximately 0.9%.

synapsesocial.com/papers/6aa27a7f58559d80afc730e9 https://doi.org/10.7759/cureus.115885

View Full Paper

Ask AI

Bookmark

Imaging Pulmonary Embolism in the Era of Subsegmental Clots: What the Internist Needs to Know About Overdiagnosis, Anticoagulation, and Follow-Up

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Imaging Pulmonary Embolism in the Era of Subsegmental Clots: What the Internist Needs to Know About Overdiagnosis, Anticoagulation, and Follow-Up

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Also Consider

Also Consider